Coverage at a glance
| Indication | Coverage |
|---|---|
| Type 2 diabetes | Covered with prior authorization |
Plan type: Commercial non-Medicare. Each indication below lists the BMI and clinical thresholds, the prior-authorization documentation, and the published policy it comes from.
Coverage by indication
What the prior authorization needs:
- Documented diagnosis of type 2 diabetes
- Prior authorization approved before the pharmacy fills it
- Quantity limit of one pen per 28 days
- Ozempic is a preferred-brand agent, so no step through another GLP-1 is required
- Approval lasts 12 months, then must be renewed
- Type 2 diabetes diagnosis and 12-month approval terms come from the Prime Therapeutics GLP-1 agonist prior authorization criteria (effective 04-01-2026): https://web.primetherapeutics.com/provider/external/commercial/common/doc/en-us/Accord_Clinical_Criteria_Choice_Glucagon-Like_Peptide-1_GLP-1_Agonists.pdf
Source: BCBSIL 2656-Y IL Balanced Drug List, July 2026 (HCSC, Prime Therapeutics). Ozempic listed as preferred brand (P) with PA and QL of 1 pen per 28 days.. formulary. Verified August 27, 2026.
What to do next
If you qualify under one of the covered indications above, prior authorization is the path. Match the documentation in the requirements list then have your prescriber submit it. Plans that approve reassess at renewal, so know your long-term maintenance dose before you start.
- Browse the prior-authorization letter library for a template that matches your plan and indication.
- Read the full coverage picture, denial reasons, and the four appeal pathways at GLP-1 insurance coverage.
- If the prior-authorization request is denied, the appeal letter library has templates by denial reason, covering peer-to-peer review, Level 1 and Level 2 internal appeal, and external review.
- If your plan does not cover the indication you need, compare cash prices in the cost guide or check whether a clinical trial near you fits. Neither one goes through your insurer. Clinical trials cost nothing and many pay you for your time. Some participants get a placebo, decided at random.
What it costs without insurance
The programs below bill you directly. Prices checked every Monday.
Frequently asked questions
Does BCBS Illinois cover Ozempic?
Blue Cross and Blue Shield of Illinois covers Ozempic for type 2 diabetes on its 2026 commercial drug lists, where it sits as a preferred brand and requires prior authorization plus a quantity limit of one pen every 28 days. Approval requires a documented diagnosis of type 2 diabetes and runs for 12 months before it has to be renewed. BCBSIL does not cover Ozempic for weight loss, because Ozempic is FDA-approved only for type 2 diabetes. The weight-loss semaglutide is Wegovy, a separate higher-dose product with its own coverage rules. This reflects the published policy verified August 2026.
What does BCBS Illinois require to approve Ozempic?
For type 2 diabetes: Prior authorization is required, with the documentation listed in the requirements above.
Coverage for other payers
See the full payer coverage index for every plan we have sourced.
How we built this page
Each page is built from a published payer policy document, government statute, or independent formulary analysis (KFF). Every indication row carries the source URL and the date we verified it. Where a payer's policy PDF was confirmed at its public URL but served as an unreadable binary, the policy number and coverage framework were cross-checked against secondary sources; those rows are marked lower confidence. Commercial coverage often depends on whether an employer elected the weight-management benefit. Those rows say varies by plan rather than a flat yes.
This is reference information, not medical or legal advice, and not a guarantee of coverage. GLP-1 coverage policies change often. Always confirm the current policy with your insurer using the number on your card before you rely on this page. If your experience differs from what is shown here, email hello@glpchart.com with the details and we will re-verify.
